Should asymptomatic bacteriuria in otherwise healthy children be treated with antibiotics?

No, asymptomatic bacteriuria in otherwise healthy children should NOT be treated with antibiotics.

The 2019 IDSA guidelines make a strong recommendation against both screening for and treating asymptomatic bacteriuria (ASB) in healthy children, based on moderate-quality evidence showing no benefit and high-quality evidence of harm 1.

Key Evidence Supporting Non-Treatment

No Impact on Critical Outcomes

Multiple randomized controlled trials demonstrate that antibiotic treatment of ASB in children:

• Does NOT prevent symptomatic UTI or pyelonephritis 1
• Does NOT prevent renal scarring - An RCT in American schoolgirls showed no differences in renal scarring between treated and untreated groups at 4 years 1
• Does NOT affect kidney growth or function - Swedish cohort studies showed normal renal growth and concentrating capacity regardless of persistent bacteriuria 1
• Does NOT reduce VUR (vesicoureteral reflux) - British cohort showed no differences in VUR resolution between treated and untreated girls 1

Evidence of Harm from Treatment

The evidence reveals concerning risks when treating ASB:

• Paradoxical increase in acute pyelonephritis - A Swedish study found that girls with stable, long-term bacteriuria who received antibiotics (penicillin) developed acute pyelonephritis in 6 cases and cystitis in 1 case within 5 months, while those receiving erythromycin (not excreted in urine) maintained bacteriuria but had NO symptomatic infections 1
• Antimicrobial resistance development 1
• Adverse drug effects 1
• Increased healthcare costs - Screening 100,000 preschool children would result in nearly 20,000 false-positive tests and cost approximately $2 million 1

Clinical Context

ASB occurs in approximately 1-3% of healthy girls and is uncommon in infants and boys 1. While children with ASB may have a slightly higher risk of developing symptomatic UTI compared to non-bacteriuric children, this does NOT translate into worse long-term outcomes like renal scarring or renal insufficiency 1.

Important Caveats

DO NOT confuse ASB with symptomatic UTI

• Children with fever, dysuria, frequency, urgency, or other urinary symptoms require evaluation and treatment
• The key is the absence of symptoms - if symptoms are present, it's not ASB

Special populations requiring further study

The guidelines acknowledge insufficient evidence for children with:

• Neuromuscular disorders or neurogenic bladder
• Immunocompromised states

However, even in these populations, current practice shows overtreatment - one study found nearly all encounters with neurogenic bladder patients received antibiotics for ASB, highlighting the need for better stewardship 2.

Practical Algorithm

When you encounter bacteriuria in a child:

1. Assess for symptoms (fever, dysuria, frequency, urgency, abdominal/flank pain)

   • If present → Treat as symptomatic UTI
   • If absent → Proceed to step 2

2. Confirm the child is otherwise healthy

   • No neurogenic bladder
   • No immunocompromise
   • No planned urologic procedure

3. Do NOT treat - Explain to parents that:

   • Treatment provides no benefit
   • Treatment may cause harm
   • Bacteria in urine without symptoms is common and benign

4. Do NOT screen for ASB - Avoid sending urine cultures in asymptomatic children

This evidence-based approach prioritizes patient safety by avoiding unnecessary antibiotic exposure while preventing the false reassurance that treatment provides protection against future kidney damage - which the evidence clearly shows it does not 1.